Answers are grounded in this paper and cite their sources.
Autologous T cells modified to recognize novel antigen targets are a novel form of therapy for cancer. We review the various potential forms of observed and hypothetical toxicities associated with genetically modified T cells. Despite the focus on toxicities in this review, re-directed T cells represent a powerful and highly effective form of anti-cancer therapy; we remain optimistic that the common toxicities will become routinely manageable and that some theoretical toxicity will be exceedingly rare, if ever observed.
No takes yet. Share an insight, caveat, or question.
Bedoya et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: